# 4166
My blogging schedule remains erratic due to the family medical crisis, but should ease up over the next few days. At least a little. My apologies to my readers for the lack of updates. - MPC
One of the `good’ things about a pandemic is that we often devote more time, energy, and money in research and come away with a better understanding of our physiology, and the pathogenic world around us, as a result.
We are seeing scientific advances nearly every day. Not all of them are immediately actionable, of course.
Sometimes, we just get another piece of the puzzle.
Yesterday, one of those potential puzzle pieces was announced via a flurry of press releases from Harvard Medical School and the Howard Hughes Medical Institute, regarding the discovery of a flu fighting protein.
December 17, 2009
Researchers Find Human Protein that Prevents H1N1 Influenza Infection
![]()
IFITM3 was among the host factors found to inhibit influenza A virus infection in the genetic screen. When influenza virus encounters primary Chicken fibroblasts (blue), there is massive viral infection as indicated by red cells (left panel). When IFITM3 levels were increased in these cells, a strong block to influenza A virus infection occurs (right panel) even though equal amounts of virus were added in both experiments.
Howard Hughes Medical Institute researchers have identified a naturally occurring human protein that helps prevent infection by H1N1 influenza and other viruses, including West Nile and dengue virus.
A research team led by Howard Hughes Medical Institute investigator Stephen J. Elledge and his colleague, Abraham Brass, discovered that human cells respond to infection by the H1N1 influenza virus by ramping up production of proteins that have unexpectedly powerful antiviral effects. In cultured human cells, those proteins, whose functions were previously unknown, block the replication of H1N1 influenza virus, West Nile virus, and dengue virus.
![]()
“The virus replicated five to ten times better when IFITM3 wasn’t there.”
Stephen J. ElledgeThe unexpected discovery could lead to the development of more effective antiviral drugs, including prophylactic drugs that could be used to slow influenza transmission.
Related Post:
- The Many Flavors Of ILI
- Canada Releases Tamiflu From National Emergency Stockpile
- CDC Statement On This Year’s Flu Activity
- ECDC Influenza Virus Characterization
- BMC: Exploring The `Age Shift’ Of Pandemic Mortality
- PLoS One: Influenza Viral Shedding & Asymptomatic Infections
- Influenza Virus Survival At Opposite Ends Of The Humidity Spectrum
- NIVW 2012
- Revisiting The Numbers Racket
- Of Pregnancy, Flu & Autism
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- MMWR: Evaluating RIDTs
- CIDRAP: The Need For `Game Changing’ Flu Vaccines
- Study: Influenza And Heart Attacks
- ECDC: Influenza Virus Characterization – Sept 2012
- Dozens Of Ways To Spell `I-L-I’
- Companion Animals & Reverse Zoonosis
- A WHO Flu Review
- NPM12: The Rehydration Solution
- NIAID Video: How Influenza Pandemics Occur
- IDSA: Pandemic and Seasonal Influenza Preparedness
- CDC Updates Minnesota H1N2v Cases
- An Increasingly Complex Flu Field
- When Body Caught Flu Infected? flu incubation period
- HOW TO RECOGNIZE COMMON FLU FLU AND DANGEROUS to children
- Branswell On Lifting The H5N1 Research Moratorium
- The Return Of The Hygiene Hypothesis
- NIH: News From The Human Microbiome Project
- More Reaction To The Kawaoka Paper
- Nature Publishes The Kawaoka H5N1 Study
- Reminder: National Academies Webcast Today On H5N1 Research
- National Academies Webcast On H5N1 Research: May 1st
- Dutch Govt. Grants Fouchier Export License For H5N1 Research
- Fouchier Research To be Debated In The Netherlands This Week
- Royal Society H5N1 Symposium: Day 2
- Webcast: Royal Society Meeting on H5N1 Research
- The Scientist: Deliberating H5N1 Research
- NSABB Clears H5N1 Studies For Publication
- U.S. Issues New DURC Oversight Rules
- NSABB To Re-examine H5N1 Research Risks
- Dysfunctional Science
- Luck Of The Draw
- Peter Sandman On Talking To The Public About H5N1 Risks
- Laurie Garrett Dissects The Rationale For H5N1 Research
- Branswell: WHO Hopes H5N1 Studies Can Be Published By Summer
- The H5N1 Research Credibility Gap
- Science Magazine: NSABB Members React To Fouchier Statement
- ECDC Risk Assessment On H5N1 Transmissibility Studies
- Peter Doherty On H5N1 Research
- Lancet: Increasing Incidence Of Infectious Diseases In New Zealand
Widget by [ Iptek-4u ]